SCHEMBL13812005

SCHEMBL13812005

Nc1nccc(-c2ccc3noc(-c4ccc(N5CCCC(O)C5)cc4)c3c2)n1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIM1 P11309 3/20 0.58
CDK2 P24941 5/20 0.48
CDK1 P06493 5/20 0.48
IP6K1 Q92551 2/20 0.45
IP6K3 Q96PC2 2/20 0.45
IP6K2 Q9UHH9 2/20 0.45
CDC7 O00311 1/20 0.41
ROCK2 O75116 1/20 0.41
MAP4K4 O95819 1/20 0.41
GSK3B P49841 1/20 0.41
CLK4 Q9HAZ1 1/20 0.41
IRAK4 Q9NWZ3 1/20 0.41
PIM3 Q86V86 1/20 0.40
PIM2 Q9P1W9 1/20 0.40
ALOX5AP P20292 3/20 0.37
CAMKK2 Q96RR4 1/20 0.37
SYK P43405 1/20 0.37
MAPK14 Q16539 1/20 0.35
NPC1 O15118 1/20 0.35
RAB9A P51151 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13811985 0.94 PIM1 (0.60) PIM1CDK2CDK1IP6K1IP6K3
SCHEMBL13812007 0.91 PIM1 (0.52) PIM1CDK2CDK1IP6K1IP6K3
SCHEMBL4027259 0.86 PIM1 (0.67) PIM1CDK2CDK1IP6K1IP6K3
SCHEMBL13812070 0.86 PIM1 (0.54) PIM1CDK2CDK1CDC7ROCK2
SCHEMBL4033705 0.83 PIM1 (0.67) PIM1CDK2CDK1IP6K1IP6K3
SCHEMBL13812002 0.82 IP6K1 (0.41) PIM1CDK2IP6K1IP6K3IP6K2
SCHEMBL13812031 0.81 PIM1 (0.57) PIM1CDK2CDK1IP6K1IP6K3
SCHEMBL13811881 0.81 PIM1 (0.65) PIM1CDK2CDK1IP6K1IP6K3
SCHEMBL13812003 0.79 PIM1 (0.56) PIM1CDK2CDK1IP6K1IP6K3
SCHEMBL4025115 0.77 PIM1 (0.60) PIM1CDK2CDK1IP6K1IP6K3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1399440-B1 5-(2-AMINOPYRIMIDIN-4-YL)BENZISOXAZOLES AS PROTEIN KINASE INHIBITORS VERTEX PHARMA (US) 2009-06-03 EP disclosed